Helping to Advance
The Science of Healthcare
About MCHRI
Founded in 2006, Midwest Children’s Health Research Institute (MCHRI) is dedicated to improving the health of children through its involvement in Phase 2, Phase 3 and Phase 4 clinical research trials. MCHRI has worked with some of the largest healthcare manufactures in the industry to improve the quality and safety of infant formula, pediatric vaccines, and medications that contribute to a healthier child.
Latest Studies
PG4-C4931004
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a Catch Up vaccine in healthy children and adolescents. Ages ≥ 15…
PG4-C4931008
A Phase 3 study to evaluate the safety, Tolerability, and immunogenicity of a multivalent pneumococcal conjugate vaccine in healthy infants. Must be ≥42 days to ≤89 days old…
BEATRIX C1091009
A Phase 3, study to evaluate the safety, tolerability, and immunogenicity of a multivalent Group B Streptococcus vaccine in healthy pregnant women and their…
Meet the Team
Founded in 2006, by the physicians of Complete Children’s Health (CCH), Midwest Children’s Health Research Institute (MCHRI) is dedicated to improving the health of children through its involvement in Phase 2, Phase 3 and Phase 4 clinical research trials.